Back
Phathom Pharmaceuticals Vs. Theriva Biologics Industry Stock Comparison
Buy
60
PHAT
Phathom Pharmaceuticals
Last Price:
18.52
Seasonality Move:
-6.37%
Buy
58
TOVX
Theriva Biologics
Last Price:
2.22
Seasonality Move:
51.28%
Buy
60
Phathom Pharmaceuticals (PHAT)
is a Buy
Is Phathom Pharmaceuticals a Buy, Sell or Hold?
- The current Phathom Pharmaceuticals [PHAT] share price is $18.50. The Score for PHAT is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- PHAT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
58
Theriva Biologics (TOVX)
is a Buy
Is Theriva Biologics a Buy, Sell or Hold?
- The current Theriva Biologics [TOVX] share price is $2.16. The Score for TOVX is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- TOVX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PHAT Stock Price Chart
What is Phathom Pharmaceuticals's stock price today?
-
The Phathom Pharmaceuticals share price today is $18.50
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PHAT is experiencing buying pressure, which is a positive indicator for future bullish movement.
TOVX Stock Price Chart
What is Theriva Biologics's stock price today?
-
The Theriva Biologics share price today is $2.16
The current trend is relatively stagnant and TOVX is experiencing buying pressure, which is a positive indicator for future bullish movement.
PHAT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.49 | Buy |
| Relative Strength Index (14 RSI): | 59.99 | Buy |
| Chaikin Money Flow: | 1000826 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.71 - 17.89) | Buy |
| Bollinger Bands (100): | (11.46 - 17.48) | Buy |
TOVX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.1 | Sell |
| Relative Strength Index (14 RSI): | 57.58 | Buy |
| Chaikin Money Flow: | 347349 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.4 - 1.84) | Buy |
| Bollinger Bands (100): | (2.12 - 6.08) | Sell |
PHAT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 17.99 | Buy |
| 20-day SMA: | 16.82 | Buy |
| 50-day SMA: | 17.27 | Buy |
| 200-day SMA: | 11.97 | Buy |
| 8-day EMA: | 17.96 | Buy |
| 20-day EMA: | 17.35 | Buy |
| 50-day EMA: | 16.5 | Buy |
| 200-day EMA: | 13.23 | Buy |
TOVX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.82 | Buy |
| 20-day SMA: | 1.62 | Buy |
| 50-day SMA: | 2.5 | Sell |
| 200-day SMA: | 7.29 | Sell |
| 8-day EMA: | 1.89 | Buy |
| 20-day EMA: | 1.82 | Buy |
| 50-day EMA: | 2.54 | Sell |
| 200-day EMA: | 6.7 | Sell |
Phathom Pharmaceuticals Earnings Growth & PHAT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.54 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.71 per share, and an increase next year of $1.35 per share.
Theriva Biologics Earnings Growth & TOVX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.00 per share, and an increase next year of $22.60 per share.
Phathom Pharmaceuticals Technical Analysis
| Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Theriva Biologics Technical Analysis
| Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 25 | 28 | 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||